← Open Payments lookup

ANGELA QUACH: Open Payments

NPI 1770053860 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,866 in 36 payments from 15 companies in 2025. Trend: 2023 $1,913 · 2024 $2,098 · 2025 $1,866

Food & beverage: $1,573Education: $293
CompanyPaymentsAmount
Gilead Sciences, Inc.3$332
Lilly USA, LLC4$253
SOBI, INC4$206
Incyte Corporation3$183
Syndax Pharmaceuticals, Inc.5$166
GlaxoSmithKline, LLC.1$123
Adaptive Biotechnologies Corporation1$118
AstraZeneca Pharmaceuticals LP3$98
Astellas Pharma US Inc3$97
Novartis Pharmaceuticals Corporation3$89

Products named: Vemlidy, JAKAFI, AREXVY, clonoSEQ, Vonjo, CALQUENCE, SCEMBLIX, Cresemba.

Industry payments across TX — which companies pay providers there.